beta
RNN
Rexahn Pharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Rexahn Pharmaceuticals Inc is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of treatments for cancer.
Market Cap: 67.3 Million
Primary Exchange: NYSE American
Website: http://www.rexahn.com
Shares Outstanding: 31.7 Million
Float: 20.7 Million
Dividend: 0.0 (0.0%)
Beta: -0.664631
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1474 trading days
From: 2014-01-13 To: 2019-06-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-05-05 | 10.0 | 1.0 | 10.0 |